Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Viral | 24 | 2025 | 295 | 3.830 |
Why?
|
| Viral Vaccines | 9 | 2022 | 36 | 2.310 |
Why?
|
| Deer | 5 | 2025 | 16 | 2.180 |
Why?
|
| West Nile Fever | 7 | 2021 | 64 | 2.110 |
Why?
|
| Aedes | 5 | 2025 | 42 | 2.090 |
Why?
|
| Rift Valley Fever | 3 | 2022 | 8 | 2.010 |
Why?
|
| Dengue | 9 | 2024 | 100 | 1.720 |
Why?
|
| Rift Valley fever virus | 4 | 2022 | 9 | 1.640 |
Why?
|
| Texas | 13 | 2025 | 428 | 1.580 |
Why?
|
| Dengue Virus | 8 | 2021 | 89 | 1.580 |
Why?
|
| West Nile virus | 6 | 2021 | 74 | 1.570 |
Why?
|
| Seroepidemiologic Studies | 9 | 2025 | 71 | 1.330 |
Why?
|
| Culicidae | 8 | 2019 | 26 | 1.210 |
Why?
|
| Swine Diseases | 2 | 2025 | 9 | 1.130 |
Why?
|
| Flavivirus | 3 | 2025 | 16 | 1.120 |
Why?
|
| Flavivirus Infections | 2 | 2025 | 5 | 1.110 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 4 | 2022 | 11 | 1.080 |
Why?
|
| Antibodies, Neutralizing | 9 | 2023 | 118 | 1.010 |
Why?
|
| Animals | 53 | 2025 | 16695 | 0.980 |
Why?
|
| Mexico | 6 | 2025 | 286 | 0.970 |
Why?
|
| Rickettsia typhi | 1 | 2025 | 1 | 0.950 |
Why?
|
| Ticks | 1 | 2025 | 8 | 0.940 |
Why?
|
| Rickettsia rickettsii | 1 | 2025 | 3 | 0.940 |
Why?
|
| Reoviridae Infections | 1 | 2025 | 1 | 0.930 |
Why?
|
| Thogotovirus | 1 | 2025 | 2 | 0.930 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2025 | 4 | 0.930 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2025 | 3 | 0.930 |
Why?
|
| DNA Virus Infections | 1 | 2025 | 16 | 0.920 |
Why?
|
| Oviposition | 1 | 2024 | 14 | 0.900 |
Why?
|
| Leptospirosis | 3 | 2022 | 30 | 0.850 |
Why?
|
| Malaria | 3 | 2022 | 90 | 0.840 |
Why?
|
| Serologic Tests | 2 | 2020 | 45 | 0.820 |
Why?
|
| Arboviruses | 2 | 2022 | 8 | 0.790 |
Why?
|
| Peru | 18 | 2022 | 40 | 0.660 |
Why?
|
| Aotidae | 2 | 2019 | 4 | 0.630 |
Why?
|
| Sentinel Surveillance | 1 | 2019 | 24 | 0.610 |
Why?
|
| Goat Diseases | 1 | 2019 | 5 | 0.610 |
Why?
|
| Cattle | 1 | 2019 | 505 | 0.560 |
Why?
|
| Immunoglobulin G | 3 | 2025 | 253 | 0.500 |
Why?
|
| Female | 26 | 2025 | 24018 | 0.490 |
Why?
|
| Cities | 3 | 2025 | 78 | 0.460 |
Why?
|
| Insect Vectors | 7 | 2021 | 26 | 0.440 |
Why?
|
| Humans | 40 | 2025 | 42163 | 0.410 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1554 | 0.390 |
Why?
|
| Vaccines, Attenuated | 3 | 2022 | 75 | 0.390 |
Why?
|
| Floods | 1 | 2011 | 6 | 0.370 |
Why?
|
| Seasons | 5 | 2025 | 133 | 0.350 |
Why?
|
| Chagas Disease | 2 | 2022 | 101 | 0.340 |
Why?
|
| Trypanosoma cruzi | 2 | 2022 | 154 | 0.330 |
Why?
|
| Tanzania | 2 | 2019 | 26 | 0.310 |
Why?
|
| Protein Subunits | 1 | 2008 | 93 | 0.290 |
Why?
|
| Population Density | 4 | 2025 | 32 | 0.290 |
Why?
|
| Alphavirus Infections | 2 | 2006 | 7 | 0.280 |
Why?
|
| Alphavirus | 2 | 2006 | 10 | 0.280 |
Why?
|
| Pregnancy | 3 | 2025 | 1737 | 0.280 |
Why?
|
| Disease Vectors | 3 | 2012 | 11 | 0.280 |
Why?
|
| Desert Climate | 2 | 2024 | 11 | 0.280 |
Why?
|
| Dogs | 3 | 2025 | 201 | 0.280 |
Why?
|
| Mice | 12 | 2025 | 6490 | 0.280 |
Why?
|
| Phylogeny | 6 | 2024 | 740 | 0.280 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 522 | 0.280 |
Why?
|
| Animals, Wild | 2 | 2025 | 24 | 0.270 |
Why?
|
| Urban Population | 2 | 2024 | 364 | 0.270 |
Why?
|
| Culex | 2 | 2020 | 4 | 0.270 |
Why?
|
| Anopheles | 3 | 2012 | 20 | 0.270 |
Why?
|
| Swine | 2 | 2025 | 205 | 0.270 |
Why?
|
| Male | 18 | 2025 | 22779 | 0.250 |
Why?
|
| Vero Cells | 8 | 2024 | 109 | 0.250 |
Why?
|
| Interferon-beta | 2 | 2025 | 9 | 0.250 |
Why?
|
| Mice, Transgenic | 4 | 2025 | 658 | 0.250 |
Why?
|
| Pupa | 2 | 2024 | 6 | 0.240 |
Why?
|
| Larva | 3 | 2024 | 131 | 0.240 |
Why?
|
| Encephalomyelitis, Venezuelan Equine | 2 | 2020 | 2 | 0.240 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2025 | 2 | 0.240 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2025 | 3 | 0.240 |
Why?
|
| Chikungunya virus | 2 | 2018 | 18 | 0.240 |
Why?
|
| Bunyaviridae | 1 | 2025 | 5 | 0.230 |
Why?
|
| Sus scrofa | 1 | 2025 | 18 | 0.230 |
Why?
|
| Ecthyma, Contagious | 1 | 2024 | 1 | 0.230 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 117 | 0.230 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 456 | 0.220 |
Why?
|
| Cricetinae | 7 | 2012 | 241 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 4 | 2022 | 686 | 0.220 |
Why?
|
| Severe Acute Respiratory Syndrome | 3 | 2009 | 7 | 0.210 |
Why?
|
| Encephalitis Virus, Eastern Equine | 3 | 2010 | 3 | 0.210 |
Why?
|
| Adult | 11 | 2025 | 13458 | 0.210 |
Why?
|
| Viral Load | 1 | 2025 | 344 | 0.200 |
Why?
|
| Mothers | 1 | 2025 | 212 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1804 | 0.200 |
Why?
|
| Family | 1 | 2004 | 192 | 0.200 |
Why?
|
| Poxviridae | 1 | 2022 | 1 | 0.200 |
Why?
|
| Genome, Viral | 2 | 2020 | 118 | 0.190 |
Why?
|
| Virus Replication | 5 | 2019 | 318 | 0.190 |
Why?
|
| Rivers | 1 | 2022 | 50 | 0.190 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 708 | 0.190 |
Why?
|
| Infant, Newborn | 1 | 2025 | 960 | 0.190 |
Why?
|
| Fever | 1 | 2022 | 63 | 0.190 |
Why?
|
| Orthobunyavirus | 2 | 2011 | 5 | 0.180 |
Why?
|
| Triatoma | 1 | 2021 | 4 | 0.170 |
Why?
|
| Cluster Analysis | 2 | 2012 | 206 | 0.170 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2021 | 3 | 0.170 |
Why?
|
| Geography | 6 | 2012 | 107 | 0.170 |
Why?
|
| Reassortant Viruses | 2 | 2011 | 11 | 0.160 |
Why?
|
| Yellow fever virus | 2 | 2013 | 3 | 0.150 |
Why?
|
| Arbovirus Infections | 2 | 2019 | 6 | 0.150 |
Why?
|
| Senegal | 5 | 2019 | 6 | 0.150 |
Why?
|
| Goats | 1 | 2019 | 22 | 0.150 |
Why?
|
| Young Adult | 5 | 2025 | 4936 | 0.150 |
Why?
|
| Serial Passage | 2 | 2022 | 5 | 0.150 |
Why?
|
| Bunyaviridae Infections | 2 | 2011 | 7 | 0.140 |
Why?
|
| Biodiversity | 1 | 2019 | 109 | 0.140 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2009 | 35 | 0.140 |
Why?
|
| RNA Viruses | 2 | 2019 | 22 | 0.140 |
Why?
|
| Virology | 1 | 2017 | 8 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 203 | 0.140 |
Why?
|
| Yellow Fever | 2 | 2010 | 5 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 330 | 0.130 |
Why?
|
| Mesocricetus | 4 | 2010 | 56 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 32 | 0.130 |
Why?
|
| Climate | 2 | 2014 | 20 | 0.130 |
Why?
|
| Encephalomyelitis, Equine | 2 | 2007 | 2 | 0.130 |
Why?
|
| RNA, Viral | 5 | 2024 | 317 | 0.130 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 55 | 0.120 |
Why?
|
| Epitopes | 1 | 2016 | 155 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 181 | 0.120 |
Why?
|
| Ecosystem | 3 | 2012 | 171 | 0.120 |
Why?
|
| Monkeypox virus | 2 | 2005 | 2 | 0.110 |
Why?
|
| Sciuridae | 2 | 2005 | 6 | 0.110 |
Why?
|
| Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hemorrhagic Fever, Crimean | 1 | 2013 | 1 | 0.100 |
Why?
|
| Viral Structural Proteins | 1 | 2013 | 17 | 0.100 |
Why?
|
| Nucleocapsid Proteins | 1 | 2013 | 12 | 0.100 |
Why?
|
| Middle Aged | 8 | 2021 | 11819 | 0.100 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 28 | 0.100 |
Why?
|
| Insect Viruses | 1 | 2012 | 3 | 0.100 |
Why?
|
| Phlebotomus | 1 | 2012 | 2 | 0.100 |
Why?
|
| Antigens, Viral | 1 | 2013 | 50 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2013 | 41 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2013 | 88 | 0.100 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2013 | 51 | 0.100 |
Why?
|
| Vaccines, Synthetic | 3 | 2008 | 78 | 0.100 |
Why?
|
| Disease Outbreaks | 2 | 2003 | 169 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 3077 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 35 | 0.090 |
Why?
|
| Neutralization Tests | 5 | 2012 | 55 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2012 | 845 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 162 | 0.090 |
Why?
|
| Viremia | 2 | 2008 | 44 | 0.090 |
Why?
|
| Environment | 1 | 2012 | 148 | 0.090 |
Why?
|
| Cell Line | 4 | 2019 | 1416 | 0.090 |
Why?
|
| Encephalomyelitis, Eastern Equine | 1 | 2010 | 1 | 0.090 |
Why?
|
| Sigmodontinae | 1 | 2010 | 2 | 0.090 |
Why?
|
| Sparrows | 1 | 2010 | 4 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 508 | 0.080 |
Why?
|
| Data Collection | 1 | 2011 | 210 | 0.080 |
Why?
|
| Horse Diseases | 1 | 2010 | 11 | 0.080 |
Why?
|
| Yellow Fever Vaccine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Base Sequence | 4 | 2020 | 997 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1266 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2011 | 587 | 0.080 |
Why?
|
| Venezuela | 2 | 2012 | 8 | 0.080 |
Why?
|
| Proteomics | 1 | 2012 | 363 | 0.080 |
Why?
|
| Proteins | 1 | 2012 | 383 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 25 | 0.080 |
Why?
|
| Weaning | 1 | 2008 | 15 | 0.080 |
Why?
|
| Appetitive Behavior | 1 | 2008 | 16 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 26 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 58 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1001 | 0.070 |
Why?
|
| Cross Reactions | 3 | 2021 | 86 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2024 | 454 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 94 | 0.070 |
Why?
|
| Sindbis Virus | 1 | 2008 | 14 | 0.070 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Encephalitis, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Viral Envelope Proteins | 1 | 2007 | 90 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2024 | 429 | 0.070 |
Why?
|
| Endemic Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Vaccines, Subunit | 1 | 2006 | 34 | 0.060 |
Why?
|
| Molecular Epidemiology | 2 | 2003 | 58 | 0.060 |
Why?
|
| Time Factors | 2 | 2008 | 1848 | 0.060 |
Why?
|
| Horses | 2 | 2020 | 28 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 221 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1188 | 0.060 |
Why?
|
| Spleen | 4 | 2009 | 199 | 0.060 |
Why?
|
| Interferons | 1 | 2005 | 37 | 0.060 |
Why?
|
| Vaccination | 1 | 2007 | 332 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 727 | 0.060 |
Why?
|
| Orthopoxvirus | 1 | 2024 | 1 | 0.060 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2024 | 14 | 0.060 |
Why?
|
| Morocco | 1 | 2024 | 16 | 0.060 |
Why?
|
| Sheep | 1 | 2024 | 77 | 0.060 |
Why?
|
| Genome, Insect | 1 | 2024 | 11 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1559 | 0.050 |
Why?
|
| Dendritic Cells | 2 | 2016 | 130 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2004 | 87 | 0.050 |
Why?
|
| Ceratopogonidae | 1 | 2003 | 1 | 0.050 |
Why?
|
| Mississippi | 1 | 2024 | 129 | 0.050 |
Why?
|
| Bites and Stings | 1 | 2003 | 13 | 0.050 |
Why?
|
| Skin | 1 | 2024 | 185 | 0.050 |
Why?
|
| Kinetics | 2 | 2019 | 698 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 203 | 0.050 |
Why?
|
| Aging | 1 | 2008 | 764 | 0.050 |
Why?
|
| Serotyping | 3 | 2012 | 37 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2024 | 323 | 0.050 |
Why?
|
| Trisaccharides | 1 | 2022 | 11 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2012 | 1516 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 1597 | 0.050 |
Why?
|
| Incidence | 3 | 2012 | 1054 | 0.050 |
Why?
|
| Military Personnel | 1 | 2003 | 109 | 0.050 |
Why?
|
| Mucins | 1 | 2022 | 69 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 5950 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 112 | 0.040 |
Why?
|
| Cytokines | 3 | 2012 | 661 | 0.040 |
Why?
|
| New Mexico | 1 | 2021 | 36 | 0.040 |
Why?
|
| Cats | 1 | 2021 | 80 | 0.040 |
Why?
|
| Mammals | 1 | 2021 | 109 | 0.040 |
Why?
|
| Housing | 2 | 2012 | 68 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2003 | 325 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2019 | 29 | 0.040 |
Why?
|
| Demography | 3 | 2004 | 195 | 0.040 |
Why?
|
| Child | 3 | 2012 | 3381 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 189 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 188 | 0.040 |
Why?
|
| Haplorhini | 1 | 2018 | 23 | 0.040 |
Why?
|
| Africa | 1 | 2018 | 81 | 0.040 |
Why?
|
| Genomics | 1 | 2020 | 289 | 0.030 |
Why?
|
| Malaysia | 1 | 2017 | 10 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 1020 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 1574 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2021 | 461 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2009 | 124 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 1729 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2016 | 73 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 68 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 692 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 461 | 0.030 |
Why?
|
| Rain | 1 | 2014 | 10 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2803 | 0.030 |
Why?
|
| DNA Primers | 2 | 2006 | 295 | 0.030 |
Why?
|
| HLA-A2 Antigen | 1 | 2013 | 4 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2013 | 85 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 24 | 0.030 |
Why?
|
| Primate Diseases | 1 | 2012 | 4 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 124 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 135 | 0.020 |
Why?
|
| Leptospira | 2 | 2003 | 27 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 59 | 0.020 |
Why?
|
| Lung | 2 | 2006 | 484 | 0.020 |
Why?
|
| Primates | 1 | 2012 | 38 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 165 | 0.020 |
Why?
|
| Sporozoites | 1 | 2012 | 6 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 25 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 52 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 114 | 0.020 |
Why?
|
| Trees | 1 | 2012 | 21 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 78 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 69 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 420 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 102 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 113 | 0.020 |
Why?
|
| Liver | 2 | 2005 | 503 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 190 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1420 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 236 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 189 | 0.020 |
Why?
|
| Bolivia | 1 | 2010 | 9 | 0.020 |
Why?
|
| South America | 1 | 2010 | 22 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 438 | 0.020 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2010 | 14 | 0.020 |
Why?
|
| North America | 1 | 2010 | 85 | 0.020 |
Why?
|
| Fever of Unknown Origin | 1 | 2010 | 7 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 16 | 0.020 |
Why?
|
| Absenteeism | 1 | 2010 | 14 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 638 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 64 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2010 | 45 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 230 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 279 | 0.020 |
Why?
|
| Risk Factors | 2 | 2012 | 3942 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 875 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2009 | 10 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 141 | 0.020 |
Why?
|
| HIV Infections | 1 | 2003 | 2535 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 7982 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 62 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1143 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 167 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 21 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 18 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2007 | 18 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2007 | 76 | 0.020 |
Why?
|
| Brain | 2 | 2006 | 1452 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2007 | 8 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2007 | 8 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 273 | 0.020 |
Why?
|
| Carrier State | 1 | 2007 | 33 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Immunization | 1 | 2007 | 93 | 0.020 |
Why?
|
| Point Mutation | 1 | 2007 | 98 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2006 | 75 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 73 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 117 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2005 | 14 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2005 | 43 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 649 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1737 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 303 | 0.010 |
Why?
|
| Rodent Diseases | 1 | 2004 | 13 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 928 | 0.010 |
Why?
|
| Insect Bites and Stings | 1 | 2004 | 3 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2004 | 11 | 0.010 |
Why?
|
| Urban Health | 1 | 2004 | 99 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2005 | 268 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 79 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 101 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2005 | 189 | 0.010 |
Why?
|
| Heart | 1 | 2005 | 181 | 0.010 |
Why?
|
| HIV Seroprevalence | 1 | 2003 | 11 | 0.010 |
Why?
|
| Chickens | 1 | 2004 | 148 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2002 | 12 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 236 | 0.010 |
Why?
|
| Plants | 1 | 2003 | 114 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 1010 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3701 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 487 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 796 | 0.010 |
Why?
|